Pharma and life sciences agentic AI in 2026 inherits five regulatory regimes simultaneously (21 CFR Part 11, GxP under GAMP 5 Second Edition, EMA Annex 11 in 2025-2026 revision, the EMA Reflection Paper on AI in the medicinal product lifecycle, and the EU AI Act). The audit substrate that satisfies any one regime does not by default satisfy the others. The 2026 procurement gap is treating the regimes as substitutable. Four conditions materially constrain compliant deployment (validated computerised system status under GAMP 5 plus CSA; 17-field audit trail covering Part 11 + Annex 11 + Article 12 simultaneously; ALCOA+ data integrity with contemporaneous, original, enduring records; EU AI Act high-risk-system registration with Article 11 technical file plus Article 16 post-market monitoring). Three vendor postures emerge in market (pre-validated Category 4 packaging; general-purpose platform plus customer-validated wrapper; open-source stack plus customer-engineered audit substrate).

One of four legs unanchored on re-review. The claim text attributes '12% of deployments clearing 300%+ ROI with 88% at or below break-even at 12-18 months' to the Stanford DEL 2026 Enterprise AI Playbook. Full-text verification on 10 Jun 2026 found no such figure in that source: the playbook (Pereira, Graylin, Brynjolfsson, Apr 2026) studies 51 successful deployments by design and contains no ROI distribution, no 300%-plus cohort, and no break-even measurement point (full finding at AM-029, correction of 10 Jun 2026). The only verified figure carrying the same 12/88 numerals is IDC research with Lenovo (via CIO.com, Mar 2025): roughly 88% of AI proof-of-concepts never reach production and roughly 12% graduate — a pilot-to-production graduation metric, not an ROI distribution. The Gartner 28%, McKinsey 23%/17%, and MIT NANDA 95% legs verify; they support a small high-performing tail and a large struggling body, but none documents the two-peak bimodal shape the claim asserts. Status Up -> Partial.

One of three read-against anchors unanchored on re-review. The claim text cites 'Stanford Digital Economy Lab Enterprise AI Playbook (12/88 bimodal ROI distribution at 12-18 months)' and frames the realistic ROI band around 'the highest-discipline 12% cohort'. Full-text verification on 10 Jun 2026 found the playbook contains no 12/88 distribution, no bimodal ROI shape, and no 12-18-month ROI measurement point (full finding at AM-029, correction of 10 Jun 2026). The claim's core negative finding — no mid-market enterprise has produced a documented +240% ROI in 90 days under audited conditions — is unaffected; the McKinsey State of AI 2025 and MIT NANDA legs verify and continue to support it. The '12% cohort' framing has no verifiable referent. The only verified figure carrying the 12/88 numerals is IDC's pilot-graduation finding (roughly 88% of AI proof-of-concepts never reach production; via CIO.com, Mar 2025), a different metric. Status Up -> Partial.

One of four named datasets unanchored on review. The claim text names 'Stanford DEL's 12% clearing 300%+ ROI vs 88% at or below break-even' as one of four independent datasets. Full-text verification on 10 Jun 2026 found the Stanford DEL Enterprise AI Playbook contains no such distribution — it studies 51 successful deployments by design and carries no ROI-realisation failure data (full finding at AM-029, correction of 10 Jun 2026). The McKinsey (23% scaling, 17% EBIT-attribution), Gartner (28% fully paying off), and MIT NANDA (95% no measurable P&L impact) datasets verify; the claim's spine stands on three datasets rather than four. The only verified figure carrying the 12/88 numerals is IDC's pilot-graduation finding (roughly 88% of AI proof-of-concepts never reach production; via CIO.com, Mar 2025), a different metric from an ROI distribution. Status Up -> Partial.

AI agents executing financial transactions need a four-control bundle (action-approval gates by blast radius, kill-swit…

Production agentic-AI costs at scale routinely run multiples of POC projections, and a layered optimisation programme c…

GPT-5 Pro's tiered-subscription model forces enterprises to classify problems by computational difficulty — $200/month…